SIREN-NETT Journal Club

To join the Meeting:

https://bluejeans.com/7342322138

To join via Room System:

Video Conferencing System: bjn.vc -or-199.48.152.152

Meeting ID : 7342322138

To join via phone :

1)  Dial: +1.888.240.2560 (US Toll Free) (see all numbers - http://bluejeans.com/numbers)

2)  Enter Conference ID : 7342322138

Click on journal images below for articles.

James Chamberlain, MD will present: Dalziel SR, Borland ML, Furyk J, Bonisch M, Neutze J, Donath S, et al. Levetiracetam versus phenytoin for second-line treatment of convulsive status epilepticus in children (ConSEPT): an open-label, multicenter, randomized controlled trial. Published Online April 17, 2019 http://dx.doi.org/10.1016/S0140-6736(19)30722-6

Shlomo Shinnar, MD, PhD will present: Lyttle MD, Rainford NEA, Messahel S, Humphreys A, Hickey H, Woolfall K, et al. Levetiracetam versus phenytoin for second-line treatment of paediatric convulsive status epilepticus (EcLiPSE): a multicenter, open-label, randomized trial. Published Online April 17, 2019 http://dx.doi.org/10.1016/S0140-6736(19)30724-X

Editorial: Silbergleit R and Elm J. Levetiracetam no better than phenytoin in children with convulsive status epilepticus. Published Online April 17, 2019 http://dx.doi.org/10.1016/S0140-6736(19)30896-7